INT187780

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.28
First Reported 2005
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 2
Total Number 2
Disease Relevance 0.90
Pain Relevance 0

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

plasma membrane (Slc11a1) molecular_function (Slc11a1) cellular_component (Slc11a1)
biological_process (Slc11a1) lysosome (Slc11a1)
Anatomy Link Frequency
upper 1
Slc11a1 (Rattus norvegicus)
Pain Link Frequency Relevance Heat
anesthesia 3 5.00 Very Low Very Low Very Low
cva 3 5.00 Very Low Very Low Very Low
imagery 2 5.00 Very Low Very Low Very Low
palliative 1 5.00 Very Low Very Low Very Low
Deep tissue 1 5.00 Very Low Very Low Very Low
Analgesic 1 5.00 Very Low Very Low Very Low
Neuritis 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Infection 11 99.76 Very High Very High Very High
Sepsis 1 97.20 Very High Very High Very High
Transitional Cell Carcinoma 26 95.14 Very High Very High Very High
Recurrence 4 93.44 High High
Disease 6 89.20 High High
Mycobacterial Infection 16 83.84 Quite High
Cancer 31 58.28 Quite High
Residual Neoplasm 3 47.04 Quite Low
Cicatrix 5 5.00 Very Low Very Low Very Low
Immunization 4 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Significant number (78%) of normal children with previous BCG vaccination, who were Mantoux negative and received BCG as a 'diagnostic test' or as revaccination, showed, exaggerated BCG response.
Localization (response) of BCG
1) Confidence 0.28 Published 2005 Journal BMC Infect Dis Section Body Doc Link PMC1274275 Disease Relevance 0.26 Pain Relevance 0
A recently published large series of treating 133 renal units over a 20-year period demonstrated no benefit in reducing recurrence or progression with adjuvant BCG following percutaneous resection of upper tract TCC.[30] If adjuvant BCG is given, it is recommended that to avoid systemic absorption and possible sepsis, instillation of agents to the upper tract should be performed under low pressure (25 cm water) and in the absence of infection.[16] Close observation after BCG is recommended for 24 hours; with immediate cessation of therapy and prompt initiation of anti-tuberculous treatment if systemic symptoms develop.[31]

RESULTS

Localization (observation) of BCG in upper associated with infection, sepsis, transitional cell carcinoma and recurrence
2) Confidence 0.04 Published 2010 Journal Indian Journal of Urology : IJU : Journal of the Urological Society of India Section Body Doc Link PMC2938538 Disease Relevance 0.64 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox